Image of Pharmacology of Infectious Diseases & Immunizations for Advanced Pract
Live Webinar

Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians


Faculty:
Jason Cota
Duration:
Full Day
Product Code:
LWC077600
Brochure Code:
PWZ77035
Media Type:
Live Webinar - Also available: Digital Seminar


Description

Attend this seminar and learn proper prescribing, patient education and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases. Choosing an antibacterial agent can be challenging, given the plethora of drugs available on the market and the emerging trend in bacterial resistance.

You will learn the pharmacology of different classes of antimicrobials used to treat infectious disease states encountered in clinical practice. Discover the spectrums of activity, pharmacokinetic characteristics and parameters for monitoring therapeutic outcomes. Emphasis is placed on the new antimicrobials and advances in evidence-based treatment guidelines. You will leave this seminar better prepared to design appropriate and cost-effective drug regimens for improved therapeutic outcomes.

Credits


*

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after completing and passing the on-line post-test evaluation). 

Continuing Education Information: Listed below are the continuing education credit(s) currently available for this live interactive webcast. This webcast is a broadcast of a live event. You will be able to type questions to the speaker. The speaker will see the questions and address them during the presentation as time allows. Please note, your state licensing board dictates whether web based activities are an acceptable form of continuing education. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, please contact cepesi@pesi.com or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.

The planning committee and staff who controlled the content of this activity have no relevant financial relationships to disclose. For speaker disclosures, please see speaker bios.

CE Information is based on 100% attendance.


Nurses, Nurse Practitioners, and Clinical Nurse Specialists

PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses in full attendance will earn 6.25 contact hours. Partial contact hours will be awarded for partial attendance.


California Nurses

PESI, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number 17118 for 6.0 contact hours. Full attendance is required. No partial contact hours will be issued for partial attendance. 


Florida Nurses

PESI, Inc. is an approved provider with the Florida Board of Nursing, Provider # FBN2858. This course qualifies for 6.0 contact hours. 

CE Broker


Iowa Nurses

PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Full attendance at this activity qualifies for 6.3 contact hours. Full attendance in the activity is required; no partial contact hours will be issued for partial attendance. These contact hours are used for your license renewal. Please email cepesi@pesi.com with your license number, include the webcast title, speaker name and date. PESI must have this number on file in order for your hours to be valid for the webcast.


Pharmacists

ACPE

Successful completion of this application-based activity qualifies for 6.3 contact hours. PESI, Inc. is on probation as an accredited provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. Next scheduled review: June 2021. ACPE Universal Program Number: 0289-0000-17-007-L01-P. Full attendance is required. No partial contact hours will be awarded for partial attendance. Please note: Pharmacists are required to complete a program evaluation/post-test within two weeks of attending the live event if they would like their participation submitted to ACPE. A valid NABP e-Profile ID and Birthdate (MM/DD) will be required for reporting. Don’t have your e-Profile ID yet? Visit the National Association of Boards of Pharmacy (NABP) website and complete your e-profile at www.nabp.net in order to obtain your NABP e-Profile ID.​


Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME such as PESI. Physician assistants may receive a maximum of 6.0 hours for completing this program.


PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™.


Other Professions

This activity qualifies for 380 continuing education minutes as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements. 



Handouts

Faculty

Jason Cota Related seminars and products: 1

PHARMD, MS


Dr. Jason Cota, PharmD, MS, is an associate professor and the vice chair of the Pharmacy Practice Department at the University of the Incarnate Word Feik School of Pharmacy. He also has over 10 years of experience practicing as an infectious diseases clinical pharmacist at the San Antonio Military Medical Center, where he is a credentialed provider with prescriptive authority.

Dr. Cota received his Doctor of Pharmacy and a Master of Science in Advanced Pharmacy Practice with an emphasis in infectious diseases research from The University of Texas at Austin. In conjunction with his Master of Science degree program, he completed a two-year Specialty Practice Residency in Pharmacotherapy at The University of Texas Health Science Center at San Antonio with an emphasis in both infectious diseases and nephrology.

Dr. Cota is a member of the Society of Infectious Diseases Pharmacists and has given several presentations at national and international meetings. His research has focused on antimicrobial and antifungal drug dosing in patient populations that are subject to altered pharmacokinetics, including critically-ill burn patients and those receiving renal replacement therapy. He has published a number of articles and has co-authored several book chapters in the areas of infectious diseases and nephrology.

Speaker Disclosures:

Financial: Jason Cota is vice chair and associate professor at the University of the Incarnate Word Feik School of Pharmacy. He receives a speaking honorarium from Merck. Dr. Cota receives a speaking honorarium for PESI, Inc.

Non-financial: Jason Cota is a member of the Society of Infectious Diseases Pharmacists.


Additional Info

Program Information

CD/DVD

Click here to purchase the DVD or CD recording from our product store. CE hours and approvals on products may differ from live CE approvals.


Access Period for Live Webcast

For live CE credit, you must watch the live webcast in its entirety at its scheduled time and complete the CE quiz and evaluation within one week. You will have access for 90 days after the program for review.


Webcast Schedule

Please note: There will be a lunch and two 15-minute breaks; one in the morning and one in the afternoon. Lunch and break times will be announced by the speaker and at their discretion. A more detailed schedule is available upon request.


Objectives

  1. Analyze the major classes of antibiotics and their pharmacokinetic characteristics.
  2. Apply current evidenced-based approaches to select appropriate treatment regimens for common infections encountered in clinical practice.
  3. Prescribe antimicrobials based on empiric dosing recommendations.
  4. Plan goals of therapy and parameters for monitoring therapeutic response to antimicrobials.
  5. Recommend specific antimicrobial therapeutic drug monitoring to maximize efficacy and minimize toxicities (e.g., vancomycin and aminoglycosides).
  6. Develop preventative strategies to limit antimicrobial resistance.
  7. Design patient and caregiver education on the proper use of antimicrobials.

Outline

Antimicrobials

  • Drug classes
  • Pharmacokinetic Properties
    • Concentration-dependent killing
    • Time-dependent killing
    • Post-antibiotic effect
  • Common interactions with other drugs

Antibacterial Allergies - Sulfa and Penicillin

  • Define true allergy
  • Sulfonamide antibiotics vs non-antibiotics
  • Penicillin - Cephalosporin cross-sensitivity

Bacteria

  • Differentiation
  • Normal flora
  • Common pathogens

Antibacterial Resistance - Contributing Factors

  • Trends
  • Mechanisms of resistance
  • Contributing factors

Methicillin-Resistant Staphylococcus Aureus - Community versus Hospital Acquired

  • Differentiating between CA- and HA-MRSA
  • Current clinical practice guidelines
  • Pharmacologic management

Enterobacteriaceae Resistance

  • Extended Spectrum Beta-Lactamase (ESBL)
    • What are ESBLs
    • Pharmacologic management
  • Carbapenem-Resistant Enterobacteriaceae (CRE)
    • What are CREs
    • Pharmacologic management

Urinary Tract Infections

  • Bacterial Etiology, Signs and Symptoms and Diagnosis
  • Cystitis and pyelonephritis
  • Complicated and uncomplicated
  • UTIs in pregnancy
  • Treatment (IDSA Guideline Treatment Algorithm)
    • Acute
    • Recurrent and relapse

Clostridium Difficile Infection

  • Risk factors
  • Pharmacology management
  • Fecal Transplantation
  • Probiotics literature review

Community–Acquired Pneumonia

  • Bacterial etiology
  • Diagnosis
  • Typical vs. atypical
  • Treatment (IDSA/ATS Guidelines) and monitoring
    • Outpatient vs. inpatient
    • Empiric treatment

Healthcare–Associated Pneumonia

  • Bacterial etiology
  • Treatment (IDSA/ATS Guidelines)

Upper Respiratory Tract Infections

  • Sinusitis and pharyngitis
    • Etiology (Viral vs. Bacterial)
    • Treatment

Skin and Soft Tissue Infections

  • Cellulitis
  • Bacterial etiology
    • Strep. vs. Staph. vs. MRSA
    • Signs & symptoms
    • Treatment (IDSA Guidelines)

Influenza

  • Clinical features
  • Diagnosis
  • Pharmacology management

Immunizations (Adult)

  • Types of Vaccines
  • General recommendations
  • Contraindications & precautions

Target Audience

  • Nurses
  • Advanced Practice Nurses
  • Clinical Nurse Specialists
  • Pharmacists
  • Nurse Practitioners
  • Physician Assistants

Reviews

5
4
3
2
1

Overall:      4.6

Total Reviews: 271

Comments

Melissa F

"Great course, great presenter"

Lindsay H

"The speaker was great! He made the presentation interesting and engaging"

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs

We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

Please wait ...

Back to Top